Form 4: Labcorp COO Schroeder Exercises RSUs, Sells for Tax

Labcorp's EVP, President of Diagnostics and COO, Mark S. Schroeder, exercised 806 Restricted Stock Units and sold 259 shares to cover tax obligations.

Summary

• Mark S. Schroeder, EVP, President of Diagnostics & COO of Labcorp Holdings Inc. (LH), engaged in a transaction on February 11, 2026.
• Schroeder acquired 806 shares of Common Stock through the exercise of Restricted Stock Units (RSUs).
• Concurrently, 259 shares of Common Stock were disposed of at a price of $289.89 per share to satisfy tax withholding obligations.
• Following these transactions, Schroeder beneficially owns 6,473.1426 shares of Common Stock directly.
• Additionally, Schroeder holds 2,358 Restricted Stock Units, which represent the contingent right to receive one share of Common Stock each.
• The vested Restricted Stock Units were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction where an executive exercised vested Restricted Stock Units and subsequently sold a portion to cover tax obligations, which is a common practice and not indicative of a change in company outlook.

Positives

• The exercise of Restricted Stock Units by a key executive indicates a realization of value and continued participation in the company's equity.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-planned, non-opportunistic transaction.

Negatives

• A portion of the acquired shares (259 shares) was sold to cover tax withholding obligations, reducing the immediate increase in direct beneficial ownership.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on an insider's equity transactions.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU exercises followed by tax-related sales, are common across industries and typically do not signal significant shifts in company fundamentals or broader industry trends. Such transactions are often pre-scheduled under Rule 10b5-1 plans to avoid accusations of trading on material non-public information.

Comparison to Industry Standards

• Not applicable as this filing reports an individual insider transaction rather than company performance metrics or project results that can be benchmarked against industry peers.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor impact as it's a routine insider transaction, demonstrating an executive's continued equity participation while also covering tax liabilities.

Next Steps

• Future vesting of the remaining 2,358 Restricted Stock Units in equal annual installments beginning February 11, 2026.

Key Dates

Keywords

Labcorp Holdings Inc., LH, Insider Transaction, Form 4, Restricted Stock Units, RSU Exercise, Stock Sale, Executive Compensation, Mark S. Schroeder